Henry Schein (HSIC Quick QuoteHSIC - Free Report) reported $3.14 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 1.2%. EPS of $1.23 for the same period compares to $1.31 a year ago.

The reported revenue represents a surprise of -4.33% over the Zacks Consensus Estimate of $3.28 billion. With the consensus EPS estimate being $1.22, the EPS surprise was +0.82%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Henry Schein performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Geographic Revenue- North America- Dental Merchandise

  : $849 million compared to the $899.40 million average estimate based on four analysts.

• Geographic Revenue- North America- Dental Equipment

  : $280 million versus $272.52 million estimated by four analysts on average.

• Geographic Revenue- International- Dental Merchandise

  : $635 million versus $660.18 million estimated by four analysts on average.

• Geographic Revenue- International- Dental Equipment

  : $160 million compared to the $172.72 million average estimate based on four analysts.

• Geographic Revenue- International- Health Care Distribution

  : $823 million compared to the $862.55 million average estimate based on four analysts. The reported number represents a change of +1.2% year over year.

• Geographic Revenue- North America- Dental

  : $1.13 billion compared to the $1.17 billion average estimate based on four analysts. The reported number represents a change of -3.4% year over year.

• Net Sales- Healthcare Distribution- Global

  : $2.92 billion versus $3.07 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +0.5% change.

• Net Sales- Healthcare Distribution- Dental- Global

  : $1.92 billion versus the six-analyst average estimate of $2.02 billion. The reported number represents a year-over-year change of -1.7%.

• Net Sales- Healthcare Distribution- Medical- Global

  : $998 million versus the six-analyst average estimate of $1.05 billion. The reported number represents a year-over-year change of +5.1%.

• Net Sales- Technology and value-added services- Global

  : $214 million compared to the $214.25 million average estimate based on six analysts. The reported number represents a change of +10.9% year over year.

• Net Sales- Healthcare Distribution- Dental Equipment- Global

  : $440 million compared to the $445.23 million average estimate based on four analysts.

• Net Sales- Healthcare Distribution- Dental Merchandise- Global

  : $1.48 billion compared to the $1.56 billion average estimate based on four analysts.

View all Key Company Metrics for Henry Schein here>>>

Shares of Henry Schein have returned +7.4% over the past month versus the Zacks S&P 500 composite's -6.7% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.